The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies

Annals of Medicine

Volumn 29, Issue 6, 1997, Pages 535-540

  Pagano, Livio ^a   Pagliari, Gabriella ^a   Basso, Agostino ^a   Marra, Roberta ^a   Sica, Simona ^a   Frigieri, Luigi ^a   Morace, Giulia ^a   Ardito, Fausta ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bronchoalveolar lavage; Leukaemia; Lymphoma; Pneumonia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; FEMALE; HUMAN; LEUKEMIA; LUNG INFECTION; LUNG LAVAGE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL;

EID: 0031428491     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899709007478     Document Type: Article

References (26)

1. Bodey GP, Powell RD, Hersh EM, Yeterian A, Freireich EJ. Pulmonary complications of acute leukemia. Cancer 1966; 19: 781-93.
2. Tenholder MF, Hooper LR. Pulmonary infiltrates in leukemia. Chest 1980; 78: 468-73.
3. Menichetti F, Martino P, Bucanee G, et al. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program. Antimicrob Agents Chemother 1994; 38: 2041-6.
4. Pennington JE, Feldman NT. Pulmonary infiltrates and fever in patients with hematologic malignacy: assessment of transbronchial biopsy. Am J Med 1977; 62: 581-7.
5. Matthay RA, Farmer WC, Odero D. Diagnostic fibreoptic bronchoscopy in the immunocompromised host with pulmonary infiltrates. Thorax 1977; 32: 539-45.
6. Castellino RA, Blank N. Etiologic diagnosis of focal pulmonary infection in immunocompromised patients by fluoroscopically guided percutaneous needle aspiration. Radiology 1979; 132: 563-7.
7. Cockerill FR III, Wilson WR, Carpenter HA, Smith TF, Rosenow EC III. Open lung biopsy in immunocompromised patients. Arch Intern Med 1985; 145: 1398-403.
8. Stover DE, Zaman MB, Hajdu SI, Lange M, Gold J, Amstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Arch Intern Med 1984; 101: 1-7.
9. Williams D, Yungbluth M, Adams G, Glassroth J. The role of fiberoptic bronchoscopy in the evaluation of immunocompromised hosts with diffuse pulmonary infiltrates. Am Rev Respir 1985; 131: 880-5.
10. Springmeyer SC, Hackman RC, Holle R, et al. Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host. J Infect Dis 1986; 154: 604-10.
11. Winthrop AL, Waddell T, Superina RA. The diagnosis of pneumonia in the immunocompromised child: use of bronchoalveolar lavage. J Pediatr Surg 1990; 25: 878-80.
12. von Eiff M, Zuhlsdorf M, Roos N, Thomas M, Buchner T, van de Loo J. Pulmonary infiltrates in patients with haematological malignancies: clinical usefulness of non-invasive bronchoscopic procedures. Eur J Haematol 1995; 54: 157-62.
13. Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992; 67: 221-7.
14. Breuer R, Lossos IS, Lafair JS, Engelhard D. Utility of bronchoalveolar lavage in the assessment of diffuse pulmonary infiltrates in nonAIDS immunocompromised patients. Respir Med 1990; 84: 313-6.
15. Singer C, Armstrong D, Rosen PP, Walzer PD, Yu B. Diffuse pulmonary infiltrates in immunosuppressed patients. Am J Med 1979; 66: 110-20.
16. Martin WJ II. Diagnostic bronchoalveolar lavage in immunosuppressed patients with new pulmonary infiltrates. Mayo Clin Proc 1992; 67: 296-8.
17. Antinori A, Pagano L, De Luca A, Marra R, Mencarini P, Tamburrini E. Role of Pneumocystis carinii DNA amplification by PCR on the diagnosis of Pneumocystis carinii pneumonia in patients with hematologic malignant diseases: report of four cases. Acta Hematol 1995; 94: 163-6.
18. Pizzo PA, Hathorn JW, Hiemenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552-8.
19. Klastersky J, Zinner SH, Calandra T, et al. for EORTC International Antimicrobial Cooperative Group. Empirical antimicrobical therapy for febrile granulocytopenic cancer patients: lesson from four EORTC trials. Eur J Cancer Clin Oncol 1988; 24: S35-45.
20. Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol 1986; 86: 518-23.
21. von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341-7.
22. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988; 94: 745-9.
23. Pohlod DJ, Saravolatz LD. Activity of quinolones against legionellaceae. J Antimicrob Chemother 1986; 17: 540-1.
24. Kotilainen P, Nikoskelainen J, Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative Staphylococcus skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990; 161: 41-4.
25. Pagano L, Laurenti L, Ortu La Barbera E, et al. Coagulase-negative Staphylococcus bacteremia in patients with haematological malignancies. An evaluation of risk factors and of antibiotic susceptibility. Abstracts of the First International Meeting on the Therapy of Infection. Florence, Italy, November 27-30, 1996.
26. Verweij PE, Latgé JP, Rijs AJ, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995; 33: 3150-3.